Children represent 23% of the U.S. population. They account for only 10% of total healthcare spending.
Yet when it comes to FDA-approved AI and machine learning devices, only 17% are labeled for pediatric use.
This isn’t just a statistical oversight. It’s a pattern that reveals where innovation dollars flow and where they don’t. While adult medicine races ahead with AI-powered diagnostics and treatment planning, Pediatric AI remains largely underdeveloped despite its revolutionary potential.
The numbers tell a story about priorities, risk tolerance, and market forces that don’t favor children.
Where the Gap Hurts Most
The consequences show up in diagnosis timelines.
Autism can be identified as early as 18 months. The average age of diagnosis in the United States? Over 4 years old.
That’s more than two years of potential early intervention lost. Two years when neural plasticity is at its peak. Two years when therapy makes the biggest difference.
The disparities get worse when you look at demographics. Hispanic children are 65% less likely to receive an autism diagnosis compared to White children. Black children are 19% less likely. Girls receive diagnoses an average of 1.5 years later than boys.
Pediatric AI technology exists to close these gaps. Canvas Dx, an FDA-authorized AI diagnostic device, uses healthcare provider inputs, caregiver observations, and video analysis to rapidly diagnose or rule out autism in young children with developmental concerns.
But one device doesn’t solve a systemic problem.
The Privacy Paradox
In March 2025, Mount Sinai launched the Center for Artificial Intelligence in Children’s Health. Their announcement acknowledged something the industry rarely says out loud: “Pediatric medicine has lagged due to stricter privacy considerations.”
This creates a paradox.
The regulations designed to protect children also slow the development of tools that could help them. Pediatric data is harder to collect, harder to share, and comes with legal complexities that make it less attractive for AI developers.
The result? Adult datasets grow massive while pediatric datasets remain fragmented and small. Pediatric AI models trained on millions of patient encounters remain scarce compared to their adult counterparts.
One exception: A Pediatric AI-based natural language processing model trained on 101.6 million data points from approximately 1.4 million pediatric patient encounters. The model demonstrated performance levels comparable to physicians across five expertise cohorts, diagnosing everything from acute sinusitis to critical conditions like meningitis and encephalitis.
This proves Pediatric AI can work when the data infrastructure exists.
What Happens When AI Reaches Children
The early results show promise beyond faster diagnosis.
A randomized controlled trial of 41 children aged 8-12 with ADHD tested AI-powered therapy games against regular entertainment games. The AI therapy group showed significant reductions in impulsiveness and inattention.
The deeper finding came from MEG brain scans. Brain activity patterns in the AI therapy group started to normalize. Improvements in impulse control connected directly to normalization of brain activity in the parieto-temporal cortex.
The therapy wasn’t just changing behavior. It was influencing underlying brain function.
In autism therapy, a 12-month study of 43 children aged 2-18 used the CognitiveBotics Pediatric AI platform alongside continuous therapy. Parents using the platform observed better improvements compared to the control group receiving only traditional therapy.
The platform runs on laptops and tablets. Common devices. Affordable technology. This matters because it makes parent-mediated interventions accessible beyond specialized clinical settings.
The Engagement Problem Traditional Therapy Can’t Solve
Children’s Hospital Colorado developed VR games for physical therapy. One example: “Booger Blaster.”
Therapists report that patients who initially agree to play for 5 minutes end up playing for 45 minutes.
One parent purchased a VR headset for home use immediately after watching her son get out of bed and complete his physical therapy exercises without resistance.
This addresses something traditional therapy struggles with: sustained engagement.
Children don’t think about long-term health outcomes. They think about whether something is boring or fun. AI-powered games and VR environments make therapy feel less like medical treatment and more like play.
The hospital employs one of the few in-house gaming development teams in healthcare facilities. They incorporate AI and motion sensors to make games treatment-relevant while maintaining engagement.
What Closing the Gap Requires
The Pediatric AI gap won’t close through market forces alone.
Children don’t control healthcare spending decisions. They can’t advocate for themselves in policy discussions. The financial incentives favor adult medicine where patient volumes are higher and regulatory pathways are clearer.
Closing the gap requires intentional decisions:
Data infrastructure that makes pediatric datasets accessible while maintaining privacy protections.
Regulatory pathways designed specifically for Pediatric AI rather than adapted from adult frameworks.
Research funding directed toward pediatric-specific applications rather than assuming adult models will translate.
Clinical integration that makes AI tools practical for pediatric therapists working with limited time and resources.
The technology exists. The clinical need is documented. The outcomes data shows promise.
What’s missing is the infrastructure and investment to make Pediatric AI development as routine as adult AI development.
Until that changes, children will continue waiting years for diagnoses that could happen in months. They’ll continue missing early intervention windows. They’ll continue facing disparities that technology could reduce.
The 17% statistic isn’t just a number. It’s a measure of how much we’re willing to invest in the youngest patients who stand to benefit most from early, accurate, and engaging therapeutic interventions.
All Rights Reserved